Essais liés9clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07583030

Ouvrir le site du centre

Essais cliniques associés

9
MoléculeIndication / populationPhaseNCTTitreStatut
Laser interstitial thermal therapy Cancer Non applicable NCT07132203 Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial COMPLETED
LVIVO-TaVec400 product Myasthénie Phase 1 NCT07583030 A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases NOT_YET_RECRUITING
Yangxue Qingnao Granules (Pills) Migraine À vérifier NCT05334927 CHAIRS — China HeadAche DIsorders RegiStry RECRUITING
UX-GIP001 Épilepsie Phase 1 NCT07572812 A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy NOT_YET_RECRUITING
Nipocalimab Myasthénie Phase 3 NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis RECRUITING
filiform needling Migraine Non applicable NCT07633522 Fire Needling Plus Filiform Needling for Chronic Migraine With Comorbid Tension-Type Headache NOT_YET_RECRUITING
[18F]-APN-1607 Alzheimer Phase 3 NCT07752784 Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD. ENROLLING_BY_INVITATION
TJ0113 200mg Parkinson Phase 3 NCT07741045 Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease NOT_YET_RECRUITING
RC18 160mg Myasthénie Phase 2 NCT04302103 A Study of TACI(Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor)-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis COMPLETED